About
Edny identifies innovative external therapeutic and technology platform opportunities in both industry and academia, focusing on age-related diseases such as neurodegeneration, oncology, metabolic dysfunction, and inflammation.
After obtaining her doctoral degree in neuroscience, Edny went on to receive her MBA and hold various roles in business development, strategy, and investments in the biotech industry. Prior to joining Calico, she led business development at Caribou Biosciences, managing sourcing for a pipeline of allogeneic, “off-the-shelf,” CAR-T cell therapies for oncology, and licensing of CRISPR technologies. Previously, she worked in the business development and strategy team at Acadia Pharmaceuticals.
Education:
- Ph.D. in Neuroscience, University of Michigan
- MBA, University of Chicago, Booth School of Business
- B.S. in Biology, Massachusetts Institute of Technology
Awards:
- MIT Bioengineering Undergraduate Research Award/Whitaker Research Award, 2002
- U-M Rackham Merit Fellowship, 2004